Tondo L, Baldessarini R J, Floris G, Rudas N
International Consortium for Bipolar Disorder Research, Boston, MA, USA.
Am J Psychiatry. 1997 Apr;154(4):548-50. doi: 10.1176/ajp.154.4.548.
This study tested the hypothesis that resumption of lithium treatment of bipolar disorders may be less effective after maintenance treatment has been discontinued.
Eighty-six patients with type I or II bipolar disorder, not selected according to response to treatment, were followed prospectively during two periods of lithium maintenance treatment averaging 4.6 and 4.4 years. Morbidity (illness episodes per year, hospitalizations per year, percentage of time ill) was assessed, and use of adjunctive medication was rated.
Morbidity was similar in the first and second treatment periods (mean number of episodes = 0.83 and 0.94 per year, respectively; mean percentage of time ill = 18.0% and 24.2%), with no differences in numbers of manic and depressive episodes or differences by gender, diagnostic type, length of first treatment, interval between treatments, or discontinuation rate. There was 12.8% more use of adjunctive medication in the second period.
The efficacy of lithium did not differ significantly between the first and second treatment periods.
本研究检验了以下假设:双相情感障碍患者在停用维持治疗后重新开始锂盐治疗,效果可能较差。
86例I型或II型双相情感障碍患者,未根据治疗反应进行选择,在两个锂盐维持治疗阶段进行前瞻性随访,平均时长分别为4.6年和4.4年。评估发病率(每年的发病次数、每年的住院次数、患病时间百分比),并对辅助药物的使用进行评分。
第一个和第二个治疗阶段的发病率相似(平均发作次数分别为每年0.83次和0.94次;平均患病时间百分比分别为18.0%和24.2%),躁狂和抑郁发作次数无差异,在性别、诊断类型、首次治疗时长、治疗间隔或停药率方面也无差异。第二个阶段辅助药物的使用增加了12.8%。
第一个和第二个治疗阶段锂盐的疗效无显著差异。